EurekAlert! -
7 Nov 2019 07:00
(National University of Singapore) Researchers from the Cancer Science Institute of Singapore uncovered an enzyme which could serve as a potential biomarker for 'natural killer T cell lymphoma' and could lead to new targeting routes for treatment.
Share this Article